profit from every $100 of sales.
$0$100
CareCloud
$2.42-8.33% today
-23.9% in 1 year
1-year low $1.711-year high $3.81
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $9.54 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What CareCloud sold, what it kept, and what it did with the cash.
Sales went from $139 million in 2022 to $120 million in 2025, with $10.8 million of profit last year.
SalesProfit
CareCloud handed back 31% of the cash it generated last year.
$6M
Free cash flow 2025$21M
Bought back its own shares–
Paid as dividends$6M
Cash vs. debt$3M vs. $4M
CareCloud vs. similar companies
CareCloud grows the slowest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| CareCloud | 9.5× · Cheap | ||
 GE HealthCare Technologies | 18.0× · Fair price | ||
 BrightSpring Health Services | 74.3× · Very expensive | ||
 Tempus AI | No profit yet | ||
 HealthEquity | 39.8× · Expensive |
AI analysis
An AI analyst reads CareCloud's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 139 | 117 | 111 | 120 | |
| 54 | 46 | 50 | 56 | |
| 5 | -4 | 10 | 11 | |
| 22 | -31 | 25 | 28 | |
| 5 | -49 | 8 | 11 | |
| -0.67 | -4.11 | -0.28 | 0.10 | |
| 39.2% | 39.5% | 45.1% | 46.5% | |
| 3.4% | -3.4% | 8.8% | 9.5% | |
| 3.9% | -41.6% | 7.1% | 9.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 136 | 78 | 72 | 88 |
| Cash | 12 | 3 | 5 | 3 |
| Total debt | 14 | 15 | 3 | 4 |
| Total liabilities | 34 | 36 | 22 | 28 |
| 102 | 42 | 50 | 60 | |
| 15 | 16 | 16 | 38 | |
| 4.1% | -67.0% | 13.2% | 14.0% | |
| 5.3% | -116.7% | 15.8% | 18.1% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 21 | 15 | 21 | 29 | |
| 12 | 12 | 7 | 8 | |
| 9 | 4 | 13 | 21 | |
| Dividends paid | 15 | 14 | 0 | 6 |
| 20 | 0 | – | – | |
| 5 | 5 | 0 | 0 |
Valuation
- 9.5×
- 13.8×
- –
- 1.7×
- 0.9×
- 5.0×
- 3.7×
- 19.9%
- 10.5%
- 0.0%
Profitability
- 46.5%
- 9.5%
- 9.0%
- 22.8%
- 15.8%
- -9.5%
- 16.9%
- 11.3%
- 16.7%
- 6.1%
Growth
- −4.6%
- –
- +25.5%
- –
- +125.8%
Financial health
- 0.1×
- 0.10
- 6.6%
- 36.7×
- 1.11
- 1.09
- 1.43
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 14%of 946
Top 49%of 871
Top 9%of 563
Bottom 10%of 867
Top 3%of 986
What analysts expect
- Average price target
- $3.25
- Range
- $3.25 – $3.25
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 0.05 | 0.06 | −16.7% |
| Mar 12, 2026 | 0.11 | 0.11 | +0.0% |
| Nov 6, 2025 | 0.10 | 0.08 | +25.0% |
| Aug 5, 2025 | 0.07 | 0.08 | −12.5% |
| May 6, 2025 | 0.05 | 0.07 | −28.6% |
| Mar 13, 2025 | 0.23 | 0.22 | +4.5% |
| Nov 12, 2024 | 0.21 | 0.22 | −4.5% |
| Aug 13, 2024 | 0.18 | 0.12 | +50.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
60Pass
Benjamin Graham
59No pass
Philip Fisher
56No pass
Peter Lynch
44No pass
Joel Greenblatt
57No pass
Charlie Munger
54No pass
Terry Smith
42No pass
Questions about CareCloud
Is CareCloud a good stock to buy?
A solid business, and the price looks low. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the CareCloud AI analysis
What does CareCloud do?
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It is in Medical - Healthcare Information Services.
Does CareCloud pay a dividend?
Yes. In 2025 it paid out $6.30 million in dividends.
Is CareCloud stock halal?
Yes. CareCloud passes our halal screen: its business is permitted and its debt is 4% of its market value, under the 30% limit. How we check
How has CareCloud stock done over the past year?
Down 23.9% over the past twelve months, to $2.42. It traded between $1.71 and $3.81 and is 36.5% below its high.
Who are CareCloud's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, BrightSpring Health Services, Tempus AI and HealthEquity. The peers table on this page compares their profit, growth and price with CareCloud's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.